Fauci believes J&J vaccine will 'get back on track'
Video Credit: Reuters - Politics - Duration: 02:19s - Published
Fauci believes J&J vaccine will 'get back on track'
Anthony Fauci, the top U.S. infectious disease doctor, hopes U.S. regulators will make a quick decision to lift a pause on the Johnson & Johnson vaccine and get that vaccine "back on track," he said in an interview with Reuters on Thursday.
Top U.S. infectious diseases expert Anthony Fauci believes Johnson & Johnson's COVID-19 vaccine will get 'back on track' soon after reports of rare blood clotting prompted U.S. regulators to pause its use this week.
His comments come a day after advisers to the CDC delayed a vote on resuming the J&J shots, until it had more data on the risk.
Fauci told Reuters Thursday the pause is a good sign that U.S. regulators take safety seriously, but urged them to make a decision on the vaccine soon.
"You know, the concern is that the longer you draw it out the more they'll be, you know, concern about not only that that vaccine, but there might even have an impact on vaccine hesitancy in general." The blood clots associated with the J&J vaccine closely resemble cases seen in Europe with the AstraZeneca vaccine.
Some European countries are already backing away from using both.
Denmark announced Wednesday it would stop using AstraZeneca's vaccine altogether.
Fauci said Thursday that decision could be premature until countries find out whether the adverse events are occurring more than they would normally.
But countries with no other vaccine options may have to weigh those risks against the risk of COVID-19, which has also been linked to the same type of brain blood clots.
"You know, you're really going to have to make an interesting judgment call.
If you have alternative vaccines, fine.
But if you don't, you may need to say, you know, it's a very, very small risk, but the advantage of giving people vaccines far outweighs the risk of that adverse event." Meanwhile, as more Americans receive the vaccine, pressure is mounting to further lift coronavirus restrictions.
"What has to happen before Americans get their freedoms back?" In a heated exchange with Representative Jim Jordan on Thursday, Fauci said it was still too soon to lift social distancing measures across the U.S. and hit back at claims that Americans' first amendment rights were being violated.
"I don't look at this as a liberty thing.
I look at this as a public health thing." The U.S. has reported an increase in new COVID-19 cases for four weeks in a row, according to a Reuters analysis.
India witnessed a dip in COVID-19 cases after the country reported 3,66,161 new infections in last 24 hours. With 7,45,237 active cases, COVID caseload of the country stood at 2,26,62,575. 3,754 new deaths in last 24 hours took the toll to 2,46,116. So far, 1,86,71,222 people won the battle against COVID-19. According to Indian Council of Medical Research, till date 30,37,50,077 samples have been tested for COVID-19 virus. Vaccination drive is underway and 17,01,76,603 vaccine doses have been inoculated.
Amid crippling COVID-19 situation in national capital, Chief Minister Arvind Kejriwal on May 09 announced that metro rail services will remain suspended till 5 am on May 17. Delhi entered into an extended period of lockdown with strict restrictions to further curb the COVID surge. Positivity rate of Delhi dipped to 23% from 35% amid lockdown restrictions.
COVID-19 cases continue to rise in Tamil Nadu and in view of it, a two-week lockdown has been imposed in the state to contain the spread of infection. On May 10, streets in Coimbatore remained silent and deserted. However, all grocery shops will continue to work until 12 noon during the lockdown period. On May 09, TN Govt in its first meeting stressed on strict COVID-19 containment measures to rein in the virus. With 28,897 new COVID cases, Tamil Nadu reported highest-ever single day spike on May 09.
The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency's plans. Gloria Tso reports.
Anchor Lauren St. Germain and Dr. Peggy Duggan, who is the Chief Medical Officer at Tampa General Hospital, discussed what unvaccinated people need to know about the Johnson & Johnson vaccine, the importance of getting both doses (of the Pfizer or Moderna vaccine) to be fully vaccinated, and vaccine hesitancy.
With the reopening of cafés, bars, restaurants, museums and shopping centres, Copenhagen regains a semblance of normality. The reopening is, however, subject to many conditions, including in some cases the presentation of a 'coronapas' to show proof of vaccination or a negative test.
Credit: euronews (in English) Duration: 01:00Published
Rep. Jim Jordan (R-OH) got into a heated exchange with Dr. Anthony Fauci over the country’s coronavirus mitigation measures, which ended with Rep. Maxine Waters (D-CA) telling Jordan to “shut your mouth.” CNN’s Jim Acosta spoke with Waters about why she intervened in the moment.
The Taoiseach expressed hope that Ireland can look forward to a good summer as he received his first Covid-19 vaccination.Micheal Martin was given an AstraZeneca jab at the Cork City Hall vaccination centre on Sunday afternoon.
Credit: PA - Press Association STUDIO Duration: 00:30Published
Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab. The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk" of people suffering blood clots after having the jab.
Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other countries. On what basis Covishield was being made in India? It's Oxford-AstraZeneca vaccine, you can say it's British-designed product. It was made in India as the vaccine owner saw India as an efficient production venue. Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world. So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration. When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work. It also came with support from the Covax initiative. So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."